Merck’s Prevnar challenger nabs FDA ‘breakthrough’ tag. Should Pfizer be worried?

글 내용 전체보기

Gilead’s hepatitis C generics are on their way, but Epclusa’s getting TV ads anyway

글 내용 전체보기

Forget the suggestion box. Merck KGaA puts employee ideas on a TED stage

글 내용 전체보기

Evolus’ Botox competitor is here. Will it dent Allergan’s sales?

글 내용 전체보기

When 2 out of 3 is bad: Teva migraine drug gets sidelined in second PBM’s formulary

글 내용 전체보기

Does Bristol-Myers Squibb’s new activist investor want to stall its Celgene buyout?

글 내용 전체보기

GenSight’s vision loss gene therapy again fails in phase 3

글 내용 전체보기

FDA rejects Alkermes’ depression drug ALKS 5461

글 내용 전체보기

Sosei spins out 2 CNS companies with help from Medicxi

글 내용 전체보기

Immuno-oncology player TCR2 Therapeutics tees up for $80M IPO

글 내용 전체보기

An atlas of HIV’s ‘escape routes’ could improve vaccine design

글 내용 전체보기

Pfizer looks to oncology biosimilars to break US market

글 내용 전체보기

Novo Nordisk DKK 9bn CapEx in 2019 ‘higher than expected’

글 내용 전체보기

Learning new vocabulary during deep sleep

글 내용 전체보기

Hitachi Chemical to acquire apceth Biopharma

글 내용 전체보기

How Type 1 Diabetes Gradually Destroys Insulin Production

글 내용 전체보기

University spinout receives £1.2 million to tackle antimicrobial resistance

글 내용 전체보기

Polymer puts new medical solutions within reach

글 내용 전체보기

Rebate Challenge Alters Drug Pricing Debate

글 내용 전체보기

IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry

글 내용 전체보기

간협, 보건복지부 간호정책 TF 설치에 ‘환영’

글 내용 전체보기